Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Influential Women Spotlights Jessie Beebe: Advancing Genetic Research & Conservation Through Expertise & Engagement
EIN Presswire
DALLAS, TX, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- Senior Research Associate at Colossal Biosciences Combines Scientific Excellence with Mentorship and Advocacy for Women in Science Jessie Beebe, Senior Research Associate at Colossal...
Latin Metals Receives C$1.875 Million from Warrant Exercises
GlobeNewswire, Inc.
VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Latin Metals Inc. ("Latin Metals" or the "Company") (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce that holders of the Company's outstanding common share purchase warrants have...
Press Release Distribution Helps Companies Build a Broader Online Footprint
EIN Presswire
NEW ORLEANS, LA, UNITED STATES, September 3, 2026 /EINPresswire.com/ -- A company’s online presence extends far beyond its website and social media profiles.
Frog Street Earns Tier 1 Curriculum Status for Preschool and Pre-K in Louisiana
EIN Presswire
First provider to achieve Tier 1; designation supports state funding alignment and high-quality classroom outcomes SOUTHLAKE, TX, UNITED STATES, April 6, 2026 /EINPresswire.com/ -- Frog Street, a trusted partner to early childhood programs...
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
GlobeNewswire, Inc.
PALO ALTO, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today that long-term efficacy...
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
GlobeNewswire, Inc.
NAARDEN, The Netherlands and MIAMI, March 23, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
MELTRIC to Showcase Water and Wastewater Solutions at WEFTEC 2026
EIN Presswire
Visit MELTRIC at Booth #9828 for hands-on demonstrations of Switch-Rated plugs and receptacles for pumps, motors, mixers, and other critical equipment.
![New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/2511067-531100496-amarin-logo-jpeg-jpg-100x20.jpeg){kind=logo}
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced that additional REDUCE-IT patient...
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s Annual Scientific Session 2026
GlobeNewswire, Inc.
– Analysis Demonstrated 22% Reduced Risk of Ischemic Stroke for Patients Taking Bempedoic Acid Compared to Placebo – – Analysis of CLEAR Outcomes Reports Bempedoic Acid Reduced MACE in High-Risk Patients with Autoimmune or Inflammatory Diseases...
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs
GlobeNewswire, Inc.
New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as well as oral antipsychotics in bipolar I disorder (BD-I) The new real-world data also show that UZEDY decreased emergency...
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
GlobeNewswire, Inc.
In a post hoc analysis of the open-label safety stage of the Phase 3 SOLARIS trial, more than half of participants receiving TEV-'749 achieved stabilization, few relapsed and more than one-fifth of participants receiving TEV-'749 for ≥ 6 months...
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
GlobeNewswire, Inc.
New data revealed that healthcare providers prioritize drowsiness risk, duration of available data demonstrating long-term response and drug-drug interaction profile when selecting a treatment for tardive dyskinesia (TD) in patients aged ≥55 years...
Louisiana Swamp Tourism Draws Increased Interest From Adventure Travelers in 2026
EIN Presswire
MARRERO, LA, UNITED STATES, December 19, 2025 /EINPresswire.com/ -- Louisiana’s swamps represent one of the most distinctive natural environments in North America, offering landscapes shaped by centuries of water flow, wildlife migration, and...
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
GlobeNewswire, Inc.
MONTREAL and CHARLOTTE, N.C., March 16, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced...
Picard Medical / SynCardia to Present its Next-Generation Emperor Total Artificial Heart Technology at the American College of Cardiology’s Annual Scientific Session
GlobeNewswire, Inc.
TUCSON, Ariz., March 20, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health...
StreamGo Names Water Industry Veteran Steve Watzeck CEO, Launches World’s First Nanobubble Capture, Concentration, and Destroy System for Long- and Short-Chain PFAS
GlobeNewswire, Inc.
ODESSA, Fla., Sept. 28, 2026 (GLOBE NEWSWIRE) -- StreamGo, a provider of advanced water and wastewater treatment systems, today announced the appointment of industry veteran Steve Watzeck as CEO and the launch of the first integrated system using...
Louisiana is open for business — and open for opportunity
Louisiana Department of Veterans Affairs
FOR IMMEDIATE RELEASE December 5, 2025 BATON ROUGE, La. – Under Governor Jeff Landry’s leadership, our state is attracting record-breaking investment, creating thousands of new jobs, and building an economy that rewards hard work and innovation....
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
GlobeNewswire, Inc.
Reviews Bempedoic Acid as Therapeutic Option for Diverse Patient Populations in Need of Alternatives to Statins in Cardiovascular Risk Management ANN ARBOR, Mich., March 17, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that two...
Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
GlobeNewswire, Inc.
NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 28, 2026 to file lead plaintiff applications in a securities class action lawsuit against...
Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo
GlobeNewswire, Inc.
New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten) SOUTH SAN FRANCISCO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced...
Sign up for:
Louisiana Tech Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.